Novo Nordisk AS (OCSE:NOVO B) Tariff Resilience Score : 8/10 (As of Jul. 22, 2025)

View and export this data going back to 1993. Start your Free Trial

What is Novo Nordisk AS Tariff Resilience Score?

Novo Nordisk AS has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Novo Nordisk AS has Novo Nordisk has a global manufacturing footprint and strong pricing power in pharmaceuticals, reducing tariff impact. Industry-specific exemptions further enhance resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Novo Nordisk AS might have Highly Resilient.

Competitive Comparison of Novo Nordisk AS's Tariff Resilience Score

For the Drug Manufacturers - General subindustry, Novo Nordisk AS's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novo Nordisk AS's Tariff Resilience Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novo Nordisk AS's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Novo Nordisk AS's Tariff Resilience Score falls into.

Save Embed

;

Save Embed

;

Novo Nordisk AS (OCSE:NOVO B) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score	Resilience Level
7 - 10	Highly Resilient
4 - 6	Average Resilient
0 - 3	Highly Vulnerable

Novo Nordisk AS Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (OCSE:NOVO B) » Definitions » Tariff Resilience Score

Comparable Companies

Traded in Other Exchanges

NONOF:USA NVO:USA NOVOB:Mexico NVO:Mexico 0TDD:UK NOVOBc:UK 0QIU:UK NOV0:Germany NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany NVON:Canada N1VO34:Brazil NOV:Bulgaria NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, 2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk AS Headlines

No Headlines